PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer

NCT06479187 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer
Hormone Sensitive Prostate Cancer
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Interventions

DRUG: 18F-rhPSMA-7.3
DEVICE: PET/CT

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]